Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
714 Phase 1a trial of PLN-101095, an integrin αvβ8 and αvβ1 inhibitor, as monotherapy and in combination with pembrolizumab, in treatment-resistant patients with advanced or metastatic solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.